evaluate novo nordisk on glp-1 agonists Free Comparison Chart: and GIP/GLP-1 Receptor for Type 2 Diabetes 🔗 Link in bio #FOAMed #Type2Diabetes #GLP1 The Battle of the Blockbusters:

Advancing basal insulin replacement in type 2 diabetes inadequately controlled with insulin glargine plus oral agents: a comparison of adding albiglutide, a weekly GLP-1 receptor agonist, versus thrice-daily prandial insulin lispro

Expert Opin Pharmacother (2006) 7:2095105

All bases covered

If you are being treated for other conditions, such as high blood pressure, cholesterol, or diabetes, some of these herbs make you more sensitive to these medications, Undeberg says

Ruth Oratz, Medical Oncologist, and Barrie Weinstein, Endocrinologist, on Thursday, February 13th as Sharsheret hosts a timely and important conversation on breast cancer and GLP-1 drugs

Compr Physiol (2014) 4(3):101755